Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006527

EVP, Research and Development acquired 191,462 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Knappertz Volker EVP, Research and Development 2023-03-02 Grant or award +191,462 344,274 D
Loading xslF345X03/wf-form4_167813808294932.xml…